EVT-101, also known as ENS-101, is an experimental medication which originated from Roche and is under development by Evotec AG for the treatment of major depressive disorder. It acts as a selective NMDA receptor subunit 2B (NR2B) antagonist.
Molekulargewicht:
318.3
CAS Nummer:
[627525-33-1]
Formel:
C16H13F3N4
Target-Kategorie:
Others
T68973
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten